SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 94.56 |
| Enterprise Value ($M) | 63.51 |
| Book Value ($M) | 32.01 |
| Book Value / Share | 1.92 |
| Price / Book | 2.95 |
| NCAV ($M) | 31.96 |
| NCAV / Share | 1.91 |
| Price / NCAV | 2.96 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.33 |
| Return on Assets (ROA) | -0.26 |
| Return on Equity (ROE) | -0.30 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 15.31 |
| Current Ratio | 15.31 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 35.51 |
| Assets | 35.55 |
| Liabilities | 3.54 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 5.55 | 0.00 | |
| 13G/A | Greenlight Capital Inc | 8.80 | -0.39 | |
| 13G/A | Hirschman Orin | 8.10 | 68.17 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,615 | 7,030 | 22.97 | |
| 8,053 | 31,869 | 25.27 | |
| 10,733 | 62,855 | 17.08 | |
(click for more detail) |
|||
Financial data and stock pages provided by
Fintel.io